Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
101,996,650
-
Number of holders
-
66
-
Total 13F shares, excl. options
-
43,302,427
-
Shares change
-
+1,822,197
-
Total reported value, excl. options
-
$429,553,897
-
Value change
-
+$13,144,675
-
Number of buys
-
38
-
Number of sells
-
-21
-
Price
-
$9.92
Significant Holders of Day One Biopharmaceuticals, Inc. - COMMON STOCK (DAWN) as of Q1 2022
75 filings reported holding DAWN - Day One Biopharmaceuticals, Inc. - COMMON STOCK as of Q1 2022.
Day One Biopharmaceuticals, Inc. - COMMON STOCK (DAWN) has 66 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 43,302,427 shares
of 101,996,650 outstanding shares and own 42% of the company stock.
Largest 10 shareholders include Canaan Partners XI LLC (9,663,645 shares), Atlas Venture Life Science Advisors, LLC (8,201,638 shares), RA CAPITAL MANAGEMENT, L.P. (6,060,090 shares), VANGUARD GROUP INC (2,986,426 shares), FMR LLC (2,594,519 shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (2,086,449 shares), PRICE T ROWE ASSOCIATES INC /MD/ (1,585,741 shares), FRANKLIN RESOURCES INC (1,542,859 shares), BOXER CAPITAL, LLC (1,189,943 shares), and BlackRock Inc. (1,162,916 shares).
This table shows the top 66 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.